Although cases of COVID-19 are declining, one segment of the population remains particularly cautious, it is cancer patients.
A new research study has begun to investigate whether the COVID-19 vaccine can prevent infection or reduce the risk of serious illness in these patients. And Amy Oshier of WINK News Health and Medical Reporter says the results are promising.
Cancer patients remain at high risk of COVID-19 infection. Dan Burgs is a patient with prostate cancer. “Well, if you have cancer, you have a damaged immune system, so I was very happy to get the vaccine,” Burgs said.
But how much difference does the vaccine make to cancer patients like Burgus? That is the question that Tamps’ Mofit Cancer Center tried to answer. Dr. Jeff Rankte is one of the lead researchers in this study. “We just tested the patient and tested the blood for antibody reactions,” said Dr. Lancet.
They followed 515 cancer patients who received the Moderna vaccine. They took blood samples again before the first and second doses of the vaccine, and one month later. Each sample was tested for COVID-19 antibody.
“More than 90% experienced a positive antibody response after the second dose, which is good,” said Dr. Lancet. “The overall response rate for patients receiving chemotherapy is high and it is good to know, so even those who like long-breast cancers and other types of cancer who have been treated with chemotherapy should be aware of it. I’m more likely to respond to the vaccine. “
The researchers measured antibody levels in 18 healthy adults receiving the same vaccine for comparison. They also saw results based on the type of cancer.
“Often, patients with chronic lymphocytic leukemia with lymphoma experienced an overall low response rate,” he said.
Moffit continues to track people who participated in the study by taking blood samples after 6, 12, and 24 months.
Copyright 2022 Fort Myers Broadcasting Company. all rights reserved. This material may not be published, broadcast, rewritten, or redistributed without prior written consent.
A new study to determine whether the COVID vaccine will prevent or reduce symptoms in cancer patients
Source link A new study to determine whether the COVID vaccine will prevent or reduce symptoms in cancer patients